Dainippon Sumitomo To Market Avapro In July
This article was originally published in PharmAsia News
Executive Summary
Dainippon Sumitomo Pharma announced June 23 it will market high blood pressure drug Avapro (irbesartan) starting July 1. Developed by Sanofi-Aventis, the drug is currently approved and sold in 86 countries. (Click here for more - Japanese language